Yingyi Qin

1.8k total citations · 1 hit paper
59 papers, 1.3k citations indexed

About

Yingyi Qin is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Surgery. According to data from OpenAlex, Yingyi Qin has authored 59 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 14 papers in Epidemiology and 13 papers in Surgery. Recurrent topics in Yingyi Qin's work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). Yingyi Qin is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). Yingyi Qin collaborates with scholars based in China, United States and Sweden. Yingyi Qin's co-authors include Jia He, Yuhao Zhou, Feifei Yu, Xin Wei, Chi Zhang, Xiaofei Ye, Jian Lu, Xinji Zhang, Xiao Zhang and Cheng Wu and has published in prestigious journals such as Nature Medicine, Gastroenterology and PLoS ONE.

In The Last Decade

Yingyi Qin

52 papers receiving 1.3k citations

Hit Papers

Adjuvant sintilimab in resected high-risk hepatocellular ... 2024 2026 2025 2024 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yingyi Qin China 18 264 259 230 219 210 59 1.3k
Shan Wu China 21 214 0.8× 181 0.7× 152 0.7× 120 0.5× 248 1.2× 69 1.2k
Xintian Cai China 24 198 0.8× 445 1.7× 93 0.4× 111 0.5× 194 0.9× 72 1.4k
Johnny Y. Jiang Hong Kong 15 137 0.5× 120 0.5× 235 1.0× 96 0.4× 181 0.9× 29 976
Apoorva K. Chandar United States 20 324 1.2× 416 1.6× 91 0.4× 261 1.2× 735 3.5× 57 1.9k
Zheng Yang China 22 145 0.5× 248 1.0× 283 1.2× 138 0.6× 191 0.9× 71 1.4k
Andromachi Vryonidou Greece 22 152 0.6× 293 1.1× 111 0.5× 101 0.5× 339 1.6× 67 1.9k
Olusegun A. Mojiminiyi Kuwait 25 165 0.6× 450 1.7× 113 0.5× 220 1.0× 196 0.9× 74 1.6k
Süleyman Serdar Koca Türkiye 20 103 0.4× 305 1.2× 117 0.5× 223 1.0× 188 0.9× 110 1.6k
Brenda Bongaerts Germany 17 65 0.2× 254 1.0× 144 0.6× 122 0.6× 127 0.6× 44 1.2k
Xiaoping Chen China 20 78 0.3× 228 0.9× 143 0.6× 66 0.3× 186 0.9× 97 1.2k

Countries citing papers authored by Yingyi Qin

Since Specialization
Citations

This map shows the geographic impact of Yingyi Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingyi Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingyi Qin more than expected).

Fields of papers citing papers by Yingyi Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingyi Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingyi Qin. The network helps show where Yingyi Qin may publish in the future.

Co-authorship network of co-authors of Yingyi Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Yingyi Qin. A scholar is included among the top collaborators of Yingyi Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingyi Qin. Yingyi Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wang, Kang, Hongming Yu, Yuqiang Cheng, et al.. (2025). Transarterial chemoembolization plus atezolizumab and bevacizumab in patients with intermediate hepatocellular carcinoma: a single-arm, phase 2 trial. Signal Transduction and Targeted Therapy. 10(1). 328–328.
4.
Xu, Ying, Yingyi Qin, Hongtao Lu, et al.. (2024). The magnesium depletion score is associated with increased likelihood of kidney stone disease among female adults. Journal of Trace Elements in Medicine and Biology. 84. 127432–127432. 7 indexed citations
7.
Li, Zhishuai, et al.. (2023). Surgical treatment of hilar cholangiocarcinoma: retrospective analysis. BJS Open. 7(3). 8 indexed citations
8.
Yang, Tao, Ying Liu, Yuanyuan Gao, et al.. (2022). Management of prostate cancer by targeting 3βHSD1 after enzalutamide and abiraterone treatment. Cell Reports Medicine. 3(5). 100608–100608. 18 indexed citations
9.
Xu, Xudong, He Qian, Yingyi Qin, et al.. (2022). Incidence and outcomes of acute high-risk chest pain diseases during pregnancy and puerperium. Frontiers in Cardiovascular Medicine. 9. 968964–968964. 1 indexed citations
10.
Li, Ming, Xiao Xu, Yingyi Qin, et al.. (2021). Radiofrequency ablation vs. stereotactic body radiotherapy for stage IA non-small cell lung cancer in nonsurgical patients. Journal of Cancer. 12(10). 3057–3066. 10 indexed citations
12.
Qin, Yingyi, Yibin Guo, Cheng Wu, et al.. (2019). Concordance of chronic conditions among the household members in Shanghai: a cross-sectional study. BMJ Open. 9(12). e031240–e031240. 4 indexed citations
13.
Zhang, Tianyi, Yuzhou Liu, Xin Wei, et al.. (2015). Effects of three injectable antidiabetic agents on glycaemic control, weight change and drop-out in type 2 diabetes suboptimally controlled with metformin and/or a sulfonylurea: A network meta-analysis. Diabetes Research and Clinical Practice. 109(3). 451–460. 14 indexed citations
14.
Liu, Y, Xiaoer Wei, Xue‐Song Zhang, et al.. (2015). Short-term weight-centric effects of tea or tea extract in patients with metabolic syndrome: a meta-analysis of randomized controlled trials. Nutrition and Diabetes. 5(6). e160–e160. 5 indexed citations
15.
Zhang, Chi, Zhiyong Wang, Yingyi Qin, Feifei Yu, & Yuhao Zhou. (2014). Association between B Vitamins Supplementation and Risk of Cardiovascular Outcomes: A Cumulative Meta-Analysis of Randomized Controlled Trials. PLoS ONE. 9(9). e107060–e107060. 30 indexed citations
16.
Zhang, Chi, Yingyi Qin, Qi Chen, et al.. (2014). Alcohol intake and risk of stroke: A dose–response meta-analysis of prospective studies. International Journal of Cardiology. 174(3). 669–677. 133 indexed citations
18.
Zhou, Yuhao, Xiaofei Ye, Feifei Yu, et al.. (2013). Lipid management in the prevention of stroke: a meta-analysis of fibrates for stroke prevention. BMC Neurology. 13(1). 1–1. 119 indexed citations
19.
Zhang, Xinji, Yesheng Li, Hui Li, et al.. (2012). Combined EGFR and VEGFR versus Single EGFR Signaling Pathways Inhibition Therapy for NSCLC: A Systematic Review and Meta-Analysis. PLoS ONE. 7(8). e40178–e40178. 8 indexed citations
20.
Ye, Xiaofei, Hong Liu, Yingyi Qin, et al.. (2011). Proton pump inhibitors therapy and risk of hip fracture. European Journal of Gastroenterology & Hepatology. 23(9). 794–800. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026